Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corbus Pharmaceuticals Holdings, Inc. - Common Stock (NQ: CRBP )

8.510 -0.970 (-10.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers
GAINERS: Nine Energy Service (NYSE: 
Via Benzinga
Corbus Pharmaceuticals: Q4 Earnings Insights
Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q4 earnings results on Tuesday, March 8, 2022 at 08:05 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Marijuana & Psychedelic Compounds-Based Drug Stocks Index Down, Again
Our index of the 13 companies working on drugs based on marijuana and/or psychedelics declined -6% last week and is now -37% YTD. 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Organogenesis Holdings (NASDAQ:ORGO 
Via Benzinga
Psychedelic & Marijuana Drug Stocks Continue To Decline
This article updates the latest stock performances of the 13 clinical-stage companies with the largest market capitalizations which are tracked in the munKNEE Pure-Play Marijuana (4) and the munKNEE... 
Via Talk Markets
Psychedelic And Cannabis Drug Stocks Continue Advance
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 338.2% to $2.82 during Thursday's pre-market session. The market value of their outstanding shares is at $284.5... 
Via Benzinga
Cannabis Stock Gainers And Losers From February 2, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 7.14% at $1.20 
Via Benzinga
Cannabis Stock Gainers And Losers From February 1, 2022
GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16 
Via Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 
Via Benzinga
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 27, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03 
Via Benzinga
Cannabis Stock Gainers And Losers From January 26, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a... 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 21, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 18, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Marijuana & Psychedelic Drug Stocks Continue To Decline
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are... 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 14, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 13, 2022
GAINERS: MGC Pharmaceuticals (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 12, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ /... 
From JTC Team, LLC
Via AccessWire
Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High
There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents. 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 7, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 6, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 5, 2022
GAINERS: Rhinomed (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 4, 2022
GAINERS: Icanic Brands (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 3, 2022
GAINERS: BioHarvest Sciences (OTC: 
Via Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... 
Via Benzinga
Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD
A look at which index has done the best so far in December: the Marijuana Drug Stocks Index or the Psychedelic Compounds-Based Drug Stocks Index. 
Via Talk Markets
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.